Welcome to our dedicated page for Prospect Capital SEC filings (Ticker: PSEC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Prospect Capital Corporation files regulatory reports that document its business development company structure, investment results, distribution policy and capital structure. Form 8-K filings cover quarterly results releases, Regulation FD distribution announcements, material agreements and financing activity involving common stock, preferred stock series and senior unsecured notes.
Proxy statements and shareholder-meeting filings describe voting matters for common and preferred stockholders, governance procedures and meeting mechanics. Prospect Capital filings also document preferred stock offering arrangements, dealer manager agreements, equity distribution agreements, dividend declarations and the security terms associated with its debt and preferred equity instruments.
Prospect Capital Corporation is offering new Prospect Capital InterNotes®, consisting of 6.250% notes due 2028, 6.500% notes due 2030, and 6.750% notes due 2032. The notes are unsecured senior obligations, pay interest semi-annually on May 15 and November 15 starting May 15, 2026, and are issued in minimum denominations of $1,000. Prospect may redeem any of the notes, in whole or in part, at $1,000 per note plus accrued interest on or after May 15, 2026. Each series includes a Survivor’s Option, allowing repayment at par plus accrued interest upon the death of a beneficial owner, subject to annual aggregate limits of the greater of $2,000,000 or 2% of notes outstanding and $250,000 per individual decedent.
Prospect Capital Corporation plans a primary debt offering of Prospect Capital InterNotes, comprising 6.250% Notes due 2028, 6.500% Notes due 2030, and 6.750% Notes due 2032. The notes are unsecured senior obligations, sold at 100.000% of principal, with semi-annual interest on May 15 and November 15, commencing May 15, 2026.
Each series is callable at 100% beginning 5/15/2026 and on every business day thereafter. Preliminary concessions to the purchasing agent are 1.125% (2028), 1.700% (2030), and 1.950% (2032). First coupon amounts per $1,000 are $30.38 (2028), $31.60 (2030), and $32.81 (2032). The notes include a Survivor’s Option as described, subject to annual caps.
Trade date is November 17, 2025; settlement on November 20, 2025. Minimum denomination is $1,000. The notes clear through DTC in book-entry form under an existing indenture with U.S. Bank National Association as trustee.
Prospect Capital Corporation furnished a press release with financial results for the fiscal quarter ended September 30, 2025, and announced cash distributions to equity holders.
Common stockholders will receive monthly dividends of $0.045 per share with record dates on 11/25/2025, 12/29/2025, and 1/28/2026, payable on 12/18/2025, 1/21/2026, and 2/18/2026, respectively.
Preferred dividends declared include: 7.50% Preferred at $0.156250 monthly; Floating Rate Preferred at $0.135417 monthly; 5.50% Preferred at $0.114583 monthly; and 6.50% Preferred at $0.135417 monthly, each with December 2025–February 2026 record dates and early following-month payments. The 5.35% Series A Preferred quarterly dividend is $0.334375 for the period noted, with a record date of 1/21/2026 and payment on 2/2/2026.
Prospect Capital Corporation reports a net increase in net assets from operations of $77.981M for the quarter ended September 30, 2025, a sharp improvement from a loss in the prior-year period. Total investment income was $157.624M, down from $196.308M a year earlier, but operating expenses also fell to $78.274M from $106.431M, resulting in net investment income of $79.350M.
After preferred dividends and related items, net income applicable to common stockholders was $48.087M, versus a loss of $165.069M a year ago. Net asset value per common share was $6.45, slightly below $6.56 at June 30, 2025, with common shares outstanding increasing to 465.9 million. Total investments at fair value were $6.513B, and net assets applicable to common shares were $3.005B, supported by a diversified portfolio of control, affiliate, and non-control investments.
Prospect Capital Corporation filed Post-Effective Amendment No. 119 to its Form N-2 registration statement (No. 333-269714). The filing was made under Rule 462(d) solely to add exhibits and, per the explanatory note, it does not modify any other part of the registration statement.
The amendment becomes effective immediately upon filing with the SEC.
Prospect Capital Corporation priced three Prospect Capital InterNotes under its shelf program. The company will issue fixed‑rate senior unsecured notes in three tranches: 6.250% Notes due 2028 with $3,383,000 principal and net proceeds of $3,344,941.25; 6.500% Notes due 2030 with $140,000 principal and net proceeds of $137,620.00; and 6.750% Notes due 2032 with $50,000 principal and net proceeds of $49,025.00.
All three tranches price at 100% of principal, pay interest semi‑annually on May 15 and November 15 (first payment May 15, 2026), include a Survivor’s Option, and are callable at 100% beginning May 15, 2026 and every business day thereafter. Trade date is November 3, 2025, with settlement on November 6, 2025, in $1,000 denominations via DTC. Recent capital actions include repurchasing $20.3 million of 3.437% 2028 Notes at 88.95%–89.95% and issuing approximately $167.6 million of 5.50% Series A Notes due 2030 in Israel, yielding net proceeds of about $159.8 million for refinancing and liquidity purposes; the Series A Notes are listed on the TASE and rated ilAA‑ by S&P Global Ratings Maalot Ltd.
Prospect Capital Corporation entered a material financing, issuing approximately $167 million aggregate principal amount of 5.5% Series A Notes due 2030. The notes are senior unsecured, pay interest quarterly starting March 31, 2026, and are expected to list on the Tel Aviv Stock Exchange on November 2, 2025. Net proceeds are estimated at $160 million, which the company expects to use primarily to refinance existing debt, including borrowings under its revolving credit facility, with any remainder for liquidity and investments aligned with its objective.
The notes may be redeemed, after 60 days from TASE listing, at the greater of par plus accrued interest, the 30‑day average closing price before board approval, or the discounted value of remaining payments, as defined in the deed of trust. Covenants include minimum total equity, a maximum net debt‑to‑total assets ratio, a minimum equity‑to‑total assets ratio, and a negative pledge. The notes, governed by Israeli law and issued under Regulation S, were sold to non‑U.S. persons offshore. The company also entered foreign exchange forwards covering expected interest and principal on the shekel‑denominated notes. Common stock is also expected to list on the TASE on November 2, 2025.
Prospect Capital Corporation filed Post-Effective Amendment No. 118 to its Form N-2 registration statement (File No. 333-269714). The filing was made under Rule 462(d) solely to add and file exhibits and, per the company, does not modify any other part of the registration statement.
The amendment becomes effective immediately upon filing with the SEC. Prospect Capital is registered as a closed-end fund regulated as a business development company. The base registration contemplates securities that may be offered from time to time after effectiveness; this amendment is an administrative update limited to exhibits.
Prospect Capital Corporation announced it priced an institutional offering of approximately $167 million in aggregate principal amount of 5.5% Series A Notes due 2030. The Notes pay interest quarterly on March 31, June 30, September 30 and December 31, commencing March 31, 2026, and mature on December 31, 2030. They are general senior unsecured obligations, ranking equally with existing and future senior unsecured debt, and are rated ilAA- by S&P Global Ratings Maalot Ltd.
The offering is expected to close on October 30, 2025, with the Notes and the Company’s common stock expected to list and commence trading on the Tel Aviv Stock Exchange on November 2, 2025. The Company may redeem the Notes, in whole or in part, at any time after 60 days from the TASE listing at the greater of par plus accrued interest, the 30-day average closing price prior to board approval, or the discounted value of remaining payments. Net proceeds are expected to be used primarily to refinance existing indebtedness, including borrowings under the revolving credit facility, with any remainder for liquidity and investments consistent with its objectives.
Prospect Capital Corporation filed a preliminary pricing supplement for new Prospect Capital InterNotes, offering fixed-rate senior unsecured notes in three tranches: 6.250% Notes due 2028, 6.500% Notes due 2030, and 6.750% Notes due 2032, each sold at 100.000% of principal. The notes pay interest semi-annually on May 15 and November 15, starting May 15, 2026, with record dates on May 1 and November 1. Each series is callable at 100.000% beginning May 15, 2026, and includes a Survivor’s Option.
The trade date is November 3, 2025 with settlement on November 6, 2025. Minimum denominations are $1,000 and integral multiples thereof, DTC book-entry only. Notes will be sold through InspereX as Purchasing Agent, with agent concessions of 1.125% (2028), 1.700% (2030), and 1.950% (2032). In recent activity, the company repurchased $20.3 million aggregate principal of its 3.437% 2028 Notes at prices of 88.95%–89.95%, plus accrued interest.